Table 1 Association of OPC with prevalence of anti-HPV IgG antibodies in a Sri Lankan study population
Characteristic | OPC cases (N = 78) | Controls (N = 51) | Chi-square | P - value | Unadjusted odds ratio (95% CI) |
|---|---|---|---|---|---|
HPV16/18Â L1 serologic status | Â | Â | Â | Â | Â |
Seronegative | 42 (53.8%) | 48 (94.12%) | Â | Â | 1.0 |
Seropositive | 36 (46%) | 3 (5.88) | 21.84 | 0.00 | 13.714(3.935-7.795) |
HPV16L1 serologic status | Â | Â | Â | Â | Â |
Seronegative | 60 (76.9%) | 48 (94.1%) | Â | Â | 1.0 |
Seropositive | 18 (23.1%) | 3 (5.8%) | 5.487 | 0.019 | 4.8 (1.335-17.261) |
HPV18 L1 serologic status | Â | Â | Â | Â | Â |
Seronegative | 53 (68%) | 50 (98.04%) | Â | Â | 1.0 |
Seropositive | 25 (32%) | 1 (1.96%) | 15.531 | 0.00 | 23.56(3.08-180.620) |